Moderna posts surprise profit as COVID vaccine sales exceed expectations
Moderna reported a surprising third-quarter profit on Thursday, driven by cost reductions and stronger-than-expected sales of its COVID-19 vaccine, despite lower-than-anticipated revenue from its new respiratory syncytial virus (RSV) vaccine. Shares of the Cambridge, Massachusetts-based company jumped 11% in premarket
Why ON Semiconductor is a strong buy despite recent market challenges
ON Semiconductor, the $31 billion chip manufacturer based in Scottsdale, Arizona, has faced significant challenges lately. Despite the broader market momentum, with the S&P 500 index climbing 29% from July 2023, ON Semi’s stock has plummeted 31%, reaching $72 from
Nissan to cut 9,000 jobs, slash profit forecast by 70% amid tough market conditions
Japan’s Nissan Motor has announced a series of aggressive cost-cutting measures, including laying off 9,000 employees and reducing its global production capacity by 20%. This marks the second time this year that the automaker has revised its profit outlook downwards